GenoMed's first HIV patient has zero viral load using blood pressure pills

By Lisa Kerner

Erie, Pa., Feb. 21 - GenoMed said its first HIV patient had his viral load fall to zero within three months of starting GenoMed's trial in August.

According to a company news release, the patient is a 54-year-old African-American man diagnosed with HIV two years ago and being treated with a standard triple-drug "cocktail."

"In this trial, we've been using blood pressure pills, for which we have a 'use' patent that is pending. Why this should work is as interesting as the fact that it has worked," GenoMed chief executive officer and chief medical officer David Moskowitz said in the release. "It points out the clinical reliability of the genomic epidemiologic data that we published in 2002."

St. Louis-based GenoMed uses a broad-spectrum, anti-viral approach and already existing, safe medication present in every drug store in the world to treat disease.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.